Russia delivered its 1st personalized cancer vaccine, Neooncovac, to a melanoma patient at the National Medical Research Center for Radiology.
A 60-year-old from the Kursk region received mRNA-based treatment alongside immunotherapy.
Significant advance in precision oncology 🇷🇺💉
Dear Readers, Good and credible news reportage is tedious task and requires huge finances.
We are soliciting your Noble support for as low as N1,000 your support would go a long way in assisting us to continue to guarantee our readers quality news.
Bank transfers can be made to:
Account Name: Harvest and Commercial
Bank: Sterling Bank
Account Number: 0078627735